Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
"Development of growth hormone secretagogues." Endocr Rev
Apitegromab selectively targets structurally distinct myostatin precursors with no binding of other targets, thus minimizing undesirable side effects 11,18,19
The recommended dosages are based on the data from clinical trials for that specific use. For both types, higher doses may lead to negative side effects Increasing the dosage for both types of medications can come with negative side effects (nausea, vomiting, constipation, fatigue, loss of appetite and more)
Side effects from both interventions should be manageable by this point
US$ 27.82
US$ 22.38
US$ 23.57
US$ 29.17
US$ 27.19
US$ 26.90
US$ 22.31
